Now in its 7th year, our annual TVM Capital Life Science Autumn Conference 2018 was held on Monday, September 17th in Montreal.
Our invitation-only conference was again attended by approx. 200 international participants from Asia, the United States and Europe who joined us to network with senior decision makers from biotech and pharmaceutical companies as well as venture capital groups and discuss latest trends in our industry as well as share expertise and experience.
Thanks to attendants and above all to our sponsors who contribute a lot to make this event happen.
Please click here to visit our photogallery of this year’s event!
For any requests please contact risman (at) tvm-capital.com.
Agenda |
|
| 12.30am | Welcome Address Luc Marengere, Managing Partner, TVM Capital Life Science |
| 12.45pm – 1:30pm | Strategic View of Oncology Therapeutic Development Jullian Jones, Sr. Director, Oncology Search & Evaluation, Eli Lilly and Company Introduction by Vanessa Grant, Norton Rose Fulbright |
| 1:30pm – 2:15pm | The Emerging Renaissance of Radiotherapy Steffen Schuster, CEO, Isotope Technologies Munich (ITM) Introduction by Stefan Fischer, CFO and General Partner, TVM Capital Life Scienc |
| 2:15pm – 3:15pm | Molecular Diagnostics and Pharmaceutical Product Development – How to Work Together to Maximise Value for all Stakeholders – Panel Discussion Andrew Schade, Distinguished Medical Fellow, Eli Lilly and Company Jean-Pascal Viola, SVP Corporate Business Development, QIAGEN Richard Watts, VP Business Development/Companion Diagnostics, QIAGEN Greg Zdechlik, COO Diagnostic Development/Commercialization, Eli Lilly and Company Moderators: Hubert Birner/Daniel Parera Introductions by Kristina Bieker-Brady, McDermott Will & Emery |
| 3:15pm – 3:45pm | Coffee Break |
| 3:45pm – 4:30pm | Alternative Strategies to Reach The Public Markets – Panel Discussion Harry Palmin, COO & CFO Acer Therapeutics David Schechner, Managing Director, R.W. Baird John Sonnier, Managing Director, William Blair David Strupp, Managing Director & Head of Healthcare Investment Banking, Ladenburg Thalmann & Co. Moderator: Luc Marengere |
| 4:30pm – 5:15pm | Transforming Knee Care: Better Outcomes, better Value for all Stakeholders Michele Laflamme, CEO, Emovi Introduction by Didier Leconte, Fonds de solidarité FTQ |
| 5:15pm – 5:30pm | Wrap up, Outlook and Acknowledgements Hubert Birner, Managing Partner, TVM Capital Life Science |
| 5:30pm | Evening Reception at Hotel Sofitel Salon Paloma Picasso |
